1.Evaluation of training in a prepractical pharmacy by students at the school of pharmacy after clinical training at hospitals or community pharmacies
Haruko YOKOYAMA ; Risa TAKAYANAGI ; Yasuhiko YAMADA
Medical Education 2010;41(6):423-427
1) The aim of this study was to develop a training method for pre-educational clinical pharmacy in a 6-year curriculum. In the evaluation of training in a prepractical pharmacy by pharmacy students after completing clinical training in a 4-year curriculum, the average scores for the necessity and usefulness of training in a prepractical pharmacy were 4.5 and 3.9, respectively (maximum score, 5; minimum score, 1).
2) The average scores for usefulness in the subcategories of knowledge, technique, and attitude were 3.5, 4.2 and 3.8, respectively. The percentages of scores of 4 or 5 in these subcategories were 60.1%, 83.2%, and 64.1%, respectively.
3) The students recognized the necessity and usefulness of training in a prepractical pharmacy, but dissociation was seen in both scores. Therefore, the amount of attitude education in training in a prepractical pharmacy was thought to be insufficient. The strong desire for education by clinical pharmacists and the development of educational programs are future challenges for the Faculty of Pharmaceutical Sciences.
2.Changes in Degree of Recognition and Understanding of Pharmacy Students and Its Evaluation in Palliative Care Education
Yasunari Mano ; Risa Hitomi ; Remi Tamura ; Yoshinori Kato ; Kaori Ohuchi ; Iori Hirosawa ; Masataka Tajima ; Jun Matsumoto ; Kayoko Maezawa ; Harumi Yamada ; Yasuyuki Momose ; Mariko Asahi
Japanese Journal of Drug Informatics 2015;17(2):100-105
Objective: In this study, we evaluated the change in degree of recognition and understanding of palliative care as pharmacy students’ years advanced.
Methods: A questionnaire survey consisting of 11 items about recognition of narcotics and 27 items about understanding of palliative care was conducted with first- to fifth-year pharmacy students. We divided the questions about the image of narcotics into groups and classified the questions about their knowledge of palliative care into the categories based on some reports.
Results: Among the three groups of questions about the image of narcotics, the degree of “right recognition of narcotics” increased, and those of “wrong recognition of narcotics” and “sense of resistance to narcotics” decreased as pharmacy students’ years advanced. Additionally, questions about their knowledge of palliative care were categorized into three: “basic guidelines for cancer pain relief and methods of narcotic use,” “role of pharmacists in palliative care and support for patients,” and “pharmacologic characteristics of narcotics.” Their degree of understanding of each category increased with an increase in years. Both the recognition of narcotics and understanding of palliative care changed in the fourth- and fifth-grade year students compared to the first-, second-, and third-year ones.
Conclusion: These results suggest that the recognition and understanding of palliative care changed along the same trends as pharmacy students’ years advanced. Therefore, it is important that pharmacy students acquire appropriate knowledge to play an active role in palliative care.
3.Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study.
Masakazu HATANO ; Hiroyuki KAMEI ; Risa INAGAKI ; Haruna MATSUZAKI ; Manako HANYA ; Shigeki YAMADA ; Nakao IWATA
Clinical Psychopharmacology and Neuroscience 2018;16(2):184-189
OBJECTIVE: Suvorexant is a novel hypnotic drug that does not interact with the conventional γ-aminobutyric acid (GABA)-A receptor. We investigated the method by which suvorexant was introduced in insomnia patients who were taking benzodiazepine receptor agonists (BzRA). METHODS: This was a retrospective study. We extracted clinical data for patients who were prescribed suvorexant and were already using BzRA. The patients were assigned to two groups, the switching and add-on groups. We assessed the suvorexant discontinuation rate at one month after the prescription of the drug. RESULTS: One hundred and nineteen patients were assigned to the switching group, and 109 were assigned to the add-on group. The add-on group exhibited a significantly higher all-cause discontinuation rate than the switching group (odds ratio, 2.7; 95% confidence interval, 1.5 to 5.0; adjusted p < 0.001). Intolerability was a significantly stronger risk factor for suvorexant discontinuation in the add-on group (22.0% vs. 7.6%, p < 0.002), and the most common adverse effect was oversedation. CONCLUSION: Our results show that the add-on of suvorexant increases the frequency of oversedation compared with switching in insomnia patients that are taking BzRA. However, this was only a preliminary retrospective study, and further studies will be required to confirm our findings.
Benzodiazepines*
;
Humans
;
Methods
;
Orexin Receptor Antagonists
;
Prescriptions
;
Receptors, GABA-A*
;
Retrospective Studies*
;
Risk Factors
;
Sleep Initiation and Maintenance Disorders*
4.Successful treatment of non-IgM lymphoplasmacytic lymphoma by bortezomib-containing regimen: case reports and review of literature
Kenichi ITO ; Risa NISHIYAMA ; Kazuhiko HIRANO ; Kazuaki YAMADA ; Naohiro SEKIGUCHI
Blood Research 2019;54(3):236-240
No abstract available.
Lymphoma
5.Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
Risa YAMADA ; Takeshi FUJII ; Kotaro HATTORI ; Hiroaki HORI ; Ryo MATSUMURA ; Tomoko KURASHIMO ; Naoko ISHIHARA ; Sumiko YOSHIDA ; Tomiki SUMIYOSHI ; Hiroshi KUNUGI
Clinical Psychopharmacology and Neuroscience 2023;21(2):296-303
Objective:
This study aimed to determine if the discrepancy between depression severity rated by clinicians and that reported by patients depends on key behavioral/psychological features in patients with mood disorders.
Methods:
Participants included 100 patients with mood disorders. First, we examined correlations and regressions between scores on the Hamilton Depression Rating Scale (HAMD) and Beck Depression Inventory (BDI). Second, we divided the participants into those who provided 1) greater ratings for the BDI compared with the HAMD (BDI relative-overrating, BO) group, 2) comparable ratings for the BDI and HAMD (BDI relatively concordant, BC) group, or 3) less ratings for the BDI (BDI relative-underrating, BU) group. Adverse childhood experiences, autistic-like traits, and coping styles were evaluated with a six-item short version of the Childhood Trauma Questionnaire (CTQ-6), the Social Responsiveness Scale for Adults (SRS-A), and the Ways of Coping Checklist (WCCL), respectively.
Results:
A significant correlation was found between HAMD and BDI scores. Total and emotional abuse subscale scores from the CTQ-6, and the self-blame subscale scores from the WCCL were significantly higher for the BO group compared with the BU group. The BO group also elicited significantly higher SRS-A total scores than did the other groups.
Conclusion
These findings suggest that patients with adverse emotional experiences, autistic-like traits, and self-blame coping styles perceive greater distress than that evaluated objectively by clinicians. The results indicate the need for inclusion of subjective assessments to effectively evaluate depressive symptoms in patients deemed to have these psycho-behavioral concerns.